Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Clazakizumab (Anti-IL-6 / IFNb2) For research use only.
Not for use in humans.

Clazakizumab (Anti-IL-6 / IFNb2)

Synonyms:

Clazakizumab (Anti-IL-6 / IFNb2) is a monoclonal antibody targeting the IL-6 (interleukin-6). It inhibitsg the cytokine response to SARS-CoV-2 in COVID-19 and can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection. MW :145.24 KD.

Clazakizumab (Anti-IL-6 / IFNb2)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Clazakizumab (Anti-IL-6 / IFNb2) is a monoclonal antibody targeting the IL-6 (interleukin-6). It inhibitsg the cytokine response to SARS-CoV-2 in COVID-19 and can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection. MW :145.24 KD.

Product Details

CAS No. 1236278-28-6
Molecular Weight 145.24
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Clazakizumab (Anti-IL-6 / IFNb2) | Clazakizumab (Anti-IL-6 / IFNb2) supplier | purchase Clazakizumab (Anti-IL-6 / IFNb2) | Clazakizumab (Anti-IL-6 / IFNb2) cost | Clazakizumab (Anti-IL-6 / IFNb2) manufacturer | order Clazakizumab (Anti-IL-6 / IFNb2) | Clazakizumab (Anti-IL-6 / IFNb2) distributor